Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

XSEC:300357 Stock Report

Market Cap: CN¥12.5b

Zhejiang Wolwo Bio-Pharmaceutical Future Growth

Future criteria checks 5/6

Zhejiang Wolwo Bio-Pharmaceutical is forecast to grow earnings and revenue by 25.3% and 22.4% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

25.3%

Earnings growth rate

25.3%

EPS growth rate

Pharmaceuticals earnings growth20.0%
Revenue growth rate22.4%
Future return on equity17.2%
Analyst coverage

Low

Last updated16 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300357 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,5255784195244
12/31/20251,2634752984364
12/31/20241,0313841653254
9/30/2024905312147291N/A
6/30/2024891311152320N/A
3/31/2024881317145342N/A
12/31/2023848310155382N/A
9/30/2023870292117362N/A
6/30/202389331674358N/A
3/31/2023882328139389N/A
1/1/2023896349160360N/A
9/30/2022888391199369N/A
6/30/2022849372268385N/A
3/31/2022841359183316N/A
12/31/2021808338236361N/A
9/30/2021765324200307N/A
6/30/2021724319183276N/A
3/31/2021691308218288N/A
12/31/2020636278186256N/A
9/30/2020630281183267N/A
6/30/2020624275155251N/A
3/31/2020612274142252N/A
12/31/2019639298129233N/A
9/30/2019615290120232N/A
6/30/2019556259134227N/A
3/31/2019532247124197N/A
12/31/2018501233144206N/A
9/30/2018478227137173N/A
6/30/2018439211N/A169N/A
3/31/2018411200N/A178N/A
12/31/2017386186N/A159N/A
9/30/2017367175N/A150N/A
6/30/2017344154N/A137N/A
3/31/2017324139N/A128N/A
12/31/2016312129N/A123N/A
9/30/2016303129N/A127N/A
6/30/2016283121N/A116N/A
3/31/2016277122N/A121N/A
12/31/2015267118N/A115N/A
9/30/2015261116N/A107N/A
6/30/2015252112N/A110N/A
3/31/2015247110N/A101N/A
12/31/2014240100N/A84N/A
9/30/201422890N/A75N/A
6/30/201421178N/A62N/A
3/31/201420268N/A59N/A
12/31/201319471N/A58N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300357's forecast earnings growth (25.3% per year) is above the savings rate (2.9%).

Earnings vs Market: 300357's earnings (25.3% per year) are forecast to grow faster than the CN market (25% per year).

High Growth Earnings: 300357's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300357's revenue (22.4% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300357's revenue (22.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300357's Return on Equity is forecast to be low in 3 years time (17.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y